Last reviewed · How we verify
NCT03271242
Implementation of National Guidelines for Treatment of Psychoses
trial testing Systematic implementation support in Psychotic Disorders in 325 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | University Hospital, Akershus |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 325 |
| Start date | 22 June 2016 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
Drugs / interventions tested
- Systematic implementation support
- No implementation support
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
Sponsor
University Hospital, Akershus
Who can join
16 and older, any sex, with Psychotic Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a combined health services research study and a clinical patient outcomes sub-study. The aims of the study are to give new knowledge on (RQ1) current implementation in mental health services of four evidence based practices for treatment of psychoses, (RQ2) how and to what degree implementation support affects the implementation, and (RQ3) whether improved implementation is associated with better clinical course and higher patient satisfaction. Pairwise randomized study in six health trusts on implementation of the four evidence based practices physical health care, antipsychotic medication, family psychoeducation, and illness management and recovery. Data on model fidelity and patient course/experience are collected at baseline and after 6, 12 and 18 months. 39 clinical units (CMHCs/departments) choose two practices and receive implementation support on one for 18 months after randomization. RQ1 is answered from baseline data, and RQ2 and RQ3 from data after 6-18 months.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Relationship between satisfaction with mental health services, personal recovery and quality of life among service users with psychosis: a cross-sectional study.
Skar-Fröding R, Clausen HK, Šaltytė Benth J, Ruud T, et al · · 2021 · cited 18× · PMID 33964917 · DOI 10.1186/s12913-021-06409-0 -
Measuring implementation: development of the implementation process assessment tool (IPAT).
Hartveit M, Hovlid E, Nordin MHA, Øvretveit J, et al · · 2019 · cited 15× · PMID 31638967 · DOI 10.1186/s12913-019-4496-0 -
The Family Psychoeducation Fidelity Scale: Psychometric Properties.
Joa I, Johannessen JO, Heiervang KS, Sviland AA, et al · · 2020 · cited 12× · PMID 32323217 · DOI 10.1007/s10488-020-01040-3 -
Psychometric Properties of a Fidelity Scale for Illness Management and Recovery.
Egeland KM, Heiervang KS, Landers M, Ruud T, et al · · 2020 · cited 12× · PMID 31701294 · DOI 10.1007/s10488-019-00992-5 -
The Effect of Intensive Implementation Support on Fidelity for Four Evidence-Based Psychosis Treatments: A Cluster Randomized Trial.
Ruud T, Drake RE, Šaltytė Benth J, Drivenes K, et al · · 2021 · cited 11× · PMID 33871742 · DOI 10.1007/s10488-021-01136-4 -
The Physical Health Care Fidelity Scale: Psychometric Properties.
Ruud T, Høifødt TS, Hendrick DC, Drake RE, et al · · 2020 · cited 10× · PMID 32036479 · DOI 10.1007/s10488-020-01019-0 -
Associations between personal recovery and service user-rated versus clinician-rated clinical recovery, a cross-sectional study.
Skar-Fröding R, Clausen H, Šaltytė Benth J, Ruud T, et al · · 2022 · cited 9× · PMID 35042494 · DOI 10.1186/s12888-022-03691-y -
Psychometric Properties of the General Organizational Index (GOI): A Measure of Individualization and Quality Improvement to Complement Program Fidelity.
Heiervang KS, Egeland KM, Landers M, Ruud T, et al · · 2020 · cited 9× · PMID 32107674 · DOI 10.1007/s10488-020-01025-2
Verify or expand the search:
- PubMed search for NCT03271242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Other University Hospital, Akershus trials
Trials by the same sponsor.
- NCT06865027 — The Effect of Arterial Carbon Dioxide Levels on Cerebral Blood Flow and Cerebral Autoregulation in the Steep Trendelenbu · NA · enrolling by invitation
- NCT06721754 — Diabetes Related Foot Ulcers with Negative Pressure Wound Therapy · NA · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
- NCT06576752 — Management of Patients with Heart Failure At Home After Hospital Discharge · NA · recruiting
- NCT06032715 — Brief Intervention for Sleep Medication Misuse Among Elderly · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03271242 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Akershus
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03271242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing